Brain Iron Metabolism and Neurodegenerative Disorders

Iron, an essential element for central nervous system (CNS) function, has frequently been found to accumulate in brain regions that undergo degeneration in neurological diseases such as Alzheimer disease, Parkinson disease, Friedreich ataxia and other disorders. However, the precise role of iron in the cause of many neurodegenerative diseases is unclear. To assist in understanding the potential importance of iron in CNS disease, this review summarizes the present knowledge in the areas of CNS iron metabolism, homeostasis and disregulation of iron balance caused by mutations in genes encoding proteins involved in iron transport, storage and metabolism. This review encompasses neurodegenerative disorders associated with both iron overload and deficiency to highlight areas where iron misregulation is likely to be important in the pathophysiology of several human brain diseases.

[1]  C. Chiueh.  Iron overload, oxidative stress, and axonal dystrophy in brain disorders. , 2001, Pediatric neurology.

[2]  V. Seshadri,et al.  Ceruloplasmin Ferroxidase Activity Stimulates Cellular Iron Uptake by a Trivalent Cation-specific Transport Mechanism* , 1999, The Journal of Biological Chemistry.

[3]  T. Bothwell.  Overview and mechanisms of iron regulation. , 2009, Nutrition reviews.

[4]  E. Hirsch,et al.  Iron metabolism and Parkinson's disease. , 1998, Movement disorders : official journal of the Movement Disorder Society.

[5]  J. D. Robertson,et al.  Copper, iron and zinc in Alzheimer's disease senile plaques , 1998, Journal of the Neurological Sciences.

[6]  P. Riederer,et al.  Impaired iron homeostasis in Parkinson's disease. , 2000, Journal of neural transmission. Supplementum.

[7]  A. Shukla,et al.  Effect of Latent Iron Deficiency on 5‐Hydroxytryptamine Metabolism in Rat Brain , 1989, Journal of neurochemistry.

[8]  E. Morgan,et al.  Transferrin and Transferrin Receptor Function in Brain Barrier Systems , 2000, Cellular and Molecular Neurobiology.

[9]  T. Moos.  Immunohistochemical localization of intraneuronal transferrin receptor immunoreactivity in the adult mouse central nervous system , 1996, The Journal of comparative neurology.

[10]  B. Lozoff,et al.  Brain iron and behavior of rats are not normalized by treatment of iron deficiency anemia during early development. , 1996, The Journal of nutrition.

[11]  J. Gitlin,et al.  Expression of the ceruloplasmin gene in the human retina and brain: implications for a pathogenic model in aceruloplasminemia. , 1996, Human molecular genetics.

[12]  P. Hof,et al.  The iron-binding protein lactotransferrin is present in pathologic lesions in a variety of neurodegenerative disorders: a comparative immunohistochemical analysis , 1994, Brain Research.

[13]  H. Miyajima,et al.  Estimation of the gene frequency of aceruloplasminemia in Japan , 1999, Neurology.

[14]  Shawn K. Westaway,et al.  A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome , 2001, Nature Genetics.

[15]  S. Tonegawa,et al.  Heme oxygenase 1 is required for mammalian iron reutilization. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[16]  Michel Koenig,et al.  Studies of human, mouse and yeast homologues indicate a mitochondrial function for frataxin , 1997, Nature Genetics.

[17]  J. Connor,et al.  Relationship of iron to oligondendrocytes and myelination , 1996 .

[18]  E. Morgan,et al.  Cellular distribution of ferric iron, ferritin, transferrin and divalent metal transporter 1 (DMT1) in substantia nigra and basal ganglia of normal and beta2-microglobulin deficient mouse brain. , 2000, Cellular and molecular biology.

[19]  B. Carroll,et al.  Serum Melanotransferrin, p97 as a Biochemical Marker of Alzheimer's Disease , 2001, Neuropsychopharmacology.

[20]  G. Perry,et al.  Sequestration of iron by Lewy bodies in Parkinson’s disease , 2000, Acta Neuropathologica.

[21]  S. Kuroda,et al.  Hydroxyl radical and superoxide dismutase in blood of patients with Parkinson’s disease: relationship to clinical data , 1999, Journal of the Neurological Sciences.

[22]  Mark A. Smith,et al.  In Situ Oxidative Catalysis by Neurofibrillary Tangles and Senile Plaques in Alzheimer’s Disease , 2000, Journal of neurochemistry.

[23]  C. Nelson,et al.  Perinatal Iron Deficiency Decreases Cytochrome c Oxidase (CytOx) Activity in Selected Regions of Neonatal Rat Brain , 2001, Pediatric Research.

[24]  Barry Halliwell,et al.  Failure of the ubiquitin–proteasome system in Parkinson's disease , 2001, Nature Reviews Neuroscience.

[25]  J. Cooper,et al.  Clinical, biochemical and molecular genetic correlations in Friedreich's ataxia. , 2000, Human molecular genetics.

[26]  J. Connor,et al.  Iron and iron management proteins in neurobiology. , 2001, Pediatric neurology.

[27]  M. Beal,et al.  Mitochondrial dysfunction in neurodegenerative diseases. , 1998, Biochimica et biophysica acta.

[28]  K Takada,et al.  A mutation, in the iron-responsive element of H ferritin mRNA, causing autosomal dominant iron overload. , 2001, American journal of human genetics.

[29]  G. Bartzokis,et al.  MR evaluation of age-related increase of brain iron in young adult and older normal males. , 1997, Magnetic resonance imaging.

[30]  L. Bernier,et al.  Mitochondrial Iron Sequestration in Dopamine‐Challenged Astroglia: Role of Heme Oxygenase‐1 and the Permeability Transition Pore , 1999, Journal of neurochemistry.

[31]  J. Connor,et al.  Abnormal localization of iron regulatory protein in Alzheimer's disease , 1998, Brain Research.

[32]  T. Rouault,et al.  Iron on the brain , 2001, Nature Genetics.

[33]  D. Sulzer,et al.  Substantia nigra neuromelanin: structure, synthesis, and molecular behaviour , 2001, Molecular pathology : MP.

[34]  G. Bartzokis,et al.  Increased basal ganglia iron levels in Huntington disease. , 1999, Archives of neurology.

[35]  R. Brooks,et al.  T1 and T2 in the brain of healthy subjects, patients with Parkinson disease, and patients with multiple system atrophy: relation to iron content. , 1999, Radiology.

[36]  G. Arendash,et al.  Time-dependent changes in iron levels and associated neuronal loss within the substantia nigra following lesions within the neostriatum/globus pallidus complex , 1995, Neuroscience.

[37]  M. MacDonald,et al.  Frataxin gene of Friedreich's ataxia is targeted to mitochondria , 1997, Annals of neurology.

[38]  C. Palmer,et al.  A histochemical study of iron‐positive cells in the developing rat brain , 1995, The Journal of comparative neurology.

[39]  R P Allen,et al.  MRI measurement of brain iron in patients with restless legs syndrome , 2001, Neurology.

[40]  C. W. Olanow,et al.  Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease: a LAMMA study , 1992, Brain Research.

[41]  P. Riederer,et al.  Structural Characteristics of Human Substantia Nigra Neuromelanin and Synthetic Dopamine Melanins , 2000, Journal of neurochemistry.

[42]  T. Moos.  Brain iron homeostasis. , 2002, Danish medical bulletin.

[43]  T. Rouault.  Systemic iron metabolism: a review and implications for brain iron metabolism. , 2001, Pediatric neurology.

[44]  R. Klausner,et al.  Regulation of iron metabolism in eukaryotes. , 1997, Current topics in cellular regulation.

[45]  F. Oski,et al.  The effects of therapy on the developmental scores of iron-deficient infants. , 1978 .

[46]  M. V. van Eden,et al.  Intact human ceruloplasmin is required for the incorporation of iron into human ferritin. , 2000, Archives of biochemistry and biophysics.

[47]  J. Gitlin,et al.  CSF abnormalities in patients with aceruloplasminemia , 1998, Neurology.

[48]  S. Shoelson,et al.  Crystal Structure of Human Frataxin* , 2000, The Journal of Biological Chemistry.

[49]  Y. Ke,et al.  Transferrin-bound and transferrin free iron uptake by cultured rat astrocytes. , 2000, Cellular and molecular biology.

[50]  P. A. Peterson,et al.  The roles of iron in health and disease. , 2001, Molecular aspects of medicine.

[51]  J. Morgan,et al.  MPTP selectively induces haem oxygenase‐1 expression in striatal astrocytes , 2000, The European journal of neuroscience.

[52]  H. Dawson,et al.  Iron metabolism: a comprehensive review. , 2009, Nutrition reviews.

[53]  P Z Marmarelis,et al.  MRI evaluation of brain iron in earlier- and later-onset Parkinson's disease and normal subjects. , 1999, Magnetic resonance imaging.

[54]  J. Trojanowski,et al.  Neurodegeneration with Brain Iron Accumulation, Type 1 Is Characterized by α-, β-, and γ-Synuclein Neuropathology , 2000 .

[55]  C. Cahill,et al.  Translation of the Alzheimer Amyloid Precursor Protein mRNA Is Up-regulated by Interleukin-1 through 5′-Untranslated Region Sequences* , 1999, The Journal of Biological Chemistry.

[56]  C. Morris,et al.  Brain iron homeostasis. , 1992, Journal of inorganic biochemistry.

[57]  N. Andrews,et al.  Recent advances in disorders of iron metabolism: mutations, mechanisms and modifiers. , 2001, Human molecular genetics.

[58]  C. Ríos,et al.  Reduced ferroxidase activity in the cerebrospinal fluid from patients with Parkinson's disease , 1999, Neuroscience Letters.

[59]  D. Walker,et al.  Lactotransferrin immunocytochemistry in Alzheimer and normal human brain. , 1993, The American journal of pathology.

[60]  J. Connor,et al.  Distribution of transferrin and ferritin binding in normal and multiple sclerotic human brains , 1999, Journal of the Neurological Sciences.

[61]  M. Bradbury.  Transport of Iron in the Blood‐Brain‐Cerebrospinal Fluid System , 1997, Journal of neurochemistry.

[62]  P. Dallman,et al.  EFFECTS OF IRON DEFICIENCY EXCLUSIVE OF ANAEMIA , 1978, British journal of haematology.

[63]  J. States,et al.  Tryptophan Hydroxylase: Cloning and Expression of the Rat Brain Enzyme in Mammalian Cells , 1996, Journal of neurochemistry.

[64]  H. Schipper,et al.  Proinflammatory cytokines promote glial heme oxygenase‐1 expression and mitochondrial iron deposition: implications for multiple sclerosis , 2001, Journal of neurochemistry.

[65]  D. Mason,et al.  Kupffer cell staining by an HFE‐specific monoclonal antibody: implications for hereditary haemochromatosis , 1998, British journal of haematology.

[66]  Kazuhiro Iwai,et al.  Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice , 2001, Nature Genetics.

[67]  D. Herbert,et al.  Discovery of a brain promoter from the human transferrin gene and its utilization for development of transgenic mice that express human apolipoprotein E alleles. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[68]  T Walter,et al.  Iron deficiency anemia: adverse effects on infant psychomotor development. , 1989, Pediatrics.

[69]  A. Brownlie,et al.  Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter , 2000, Nature.

[70]  S. D. Brady,et al.  Haem oxygenase-1 prevents cell death by regulating cellular iron , 1999, Nature Cell Biology.

[71]  R. Bakshi,et al.  T2 hypointensity in the deep gray matter of patients with multiple sclerosis: a quantitative magnetic resonance imaging study. , 2002, Archives of neurology.

[72]  A J Barkovich,et al.  Normal deposition of brain iron in childhood and adolescence: MR imaging at 1.5 T. , 1989, Radiology.

[73]  J. Connor,et al.  Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome , 2000, Neurology.

[74]  T. Kawanami,et al.  Hereditary ceruloplasmin deficiency increases advanced glycation end products in the brain , 1999, Neurology.

[75]  M. Maines.  The heme oxygenase system and its functions in the brain. , 2000, Cellular and molecular biology.

[76]  E. Masliah,et al.  Oxidative stress induces amyloid-like aggregate formation of NACP/α-synuclein in vitro , 1999 .

[77]  J. Connor,et al.  Iron in the brain. , 2009, Nutrition reviews.

[78]  J. Connor,et al.  Brain iron, transferrin and ferritin concentrations are altered in developing iron-deficient rats. , 1995, The Journal of nutrition.

[79]  J. Connor,et al.  A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains , 1992, Journal of neuroscience research.

[80]  D. Burn,et al.  Multiple system atrophy: cellular and molecular pathology , 2001, Molecular pathology : MP.

[81]  K. Zilles,et al.  Heme Oxygenase-1 (HSP-32) and Heme Oxygenase-2 Induction in Neurons and Glial Cells of Cerebral Regions and Its Relation to Iron Accumulation after Focal Cortical Photothrombosis , 2001, Experimental Neurology.

[82]  Y Agid,et al.  Expression of lactoferrin receptors is increased in the mesencephalon of patients with Parkinson disease. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[83]  E. Beutler,et al.  Polymorphisms in the transferrin 5' flanking region associated with differences in total iron binding capacity: possible implications in iron homeostasis. , 2001, Blood cells, molecules & diseases.

[84]  J. Connor,et al.  Cellular distribution of iron in the brain of the Belgrade rat , 1999, Neuroscience.

[85]  E. Pollitt,et al.  Iron deficiency and behavior. , 1976, The Journal of pediatrics.

[86]  J. Dobson,et al.  Nanoscale biogenic iron oxides and neurodegenerative disease , 2001, FEBS letters.

[87]  Nicholas Willson,et al.  An autoradiographic study of the uptake and distribution of iron by the brain of the young rat , 1990, Brain Research.

[88]  J. Beard,et al.  Brain iron: location and function. , 1993, Progress in food & nutrition science.

[89]  S. Abboud,et al.  A Novel Mammalian Iron-regulated Protein Involved in Intracellular Iron Metabolism* , 2000, The Journal of Biological Chemistry.

[90]  R. Eisenstein.  Iron regulatory proteins and the molecular control of mammalian iron metabolism. , 2000, Annual review of nutrition.

[91]  N. Abraham,et al.  Regional distribution of heme oxygenase, HSP70, and glutathione in brain: Relevance for endogenous oxidant/antioxidant balance and stress tolerance , 2002, Journal of neuroscience research.

[92]  C. Morris,et al.  Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease , 2001, Nature Genetics.

[93]  S. David,et al.  Alternative RNA Splicing Generates a Glycosylphosphatidylinositol-anchored Form of Ceruloplasmin in Mammalian Brain* , 2000, The Journal of Biological Chemistry.

[94]  P Trouillas,et al.  Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes. , 1997, Human molecular genetics.

[95]  E. Morgan,et al.  Iron and transferrrin uptake by brain and cerebrospinal fluid in the rat , 1992, Brain Research.

[96]  S. Weis,et al.  Signal changes on MRI and increases in reactive microgliosis, astrogliosis, and iron in the putamen of two patients with multiple system atrophy. , 1996, Journal of neurology, neurosurgery, and psychiatry.

[97]  G. Perry,et al.  Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[98]  H. Schipper,et al.  Heme oxygenase-1: role in brain aging and neurodegeneration , 2000, Experimental Gerontology.

[99]  A. Nakamura,et al.  Increased lipid peroxidation in the brains of aceruloplasminemia patients , 2000, Journal of the Neurological Sciences.

[100]  P. Mantyh,et al.  Aluminum, Iron, and Zinc Ions Promote Aggregation of Physiological Concentrations of β‐Amyloid Peptide , 1993, Journal of neurochemistry.

[101]  P. Patel,et al.  Friedreich's Ataxia: Autosomal Recessive Disease Caused by an Intronic GAA Triplet Repeat Expansion , 1996, Science.

[102]  A. Munnich,et al.  Aconitase and mitochondrial iron–sulphur protein deficiency in Friedreich ataxia , 1997, Nature Genetics.

[103]  W. Jefferies,et al.  Reactive microglia specifically associated with amyloid plaques in Alzheimer's disease brain tissue express melanotransferrin , 1996, Brain Research.

[104]  J. Connor,et al.  Regional distribution of iron and iron‐regulatory proteins in the brain in aging and Alzheimer's disease , 1992, Journal of neuroscience research.

[105]  D. Dickstein,et al.  p97 as a biomarker for Alzheimer disease. , 2002, Frontiers in bioscience : a journal and virtual library.